StageZero Life Sciences Launches AVRT(TM) in the UK

Innovative program helps identify and address the early warning signs of cancer and chronic diseaseTORONTO, ON / ACCESSWIRE / March 31, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically …